查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1917792

細胞分離市場－2026-2031年預測

Cell Separation Market - Forecast from 2026 to 2031
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 145 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計細胞分離市場將從 2025 年的 70.71 億美元成長到 2031 年的 117.65 億美元，複合年成長率為 8.86%。

細胞分離市場可望持續成長，這主要得益於其在現代生物醫學研發中的基礎性作用。該領域專注於從異質混合物中分離特定細胞類型，對多個高影響力領域的發展至關重要。日益嚴峻的全球健康挑戰、生物製造的擴張以及大量的技術和資金投入，共同推動了該市場強勁的商業性成長。

市場擴張的關鍵促進因素是全球慢性疾病負擔的日益加重，尤其是癌症。細胞分離技術對於更好地了解疾病機制、識別關鍵生物標記以及開發標靶診斷和治療方法至關重要。分離和分析稀有細胞群（例如循環性腫瘤細胞(CTC)）是一項變革性應用，能夠以微創方式監測疾病進展和治療效果。這種直接針對常見癌症和其他慢性疾病的應用，確保了對先進分離解決方案的持續需求。

同時，生物製藥產業的蓬勃發展也是關鍵的成長動力。隨著對單株抗體、重組蛋白和細胞療法等複雜生物製藥的關注度不斷提高，可靠且擴充性的細胞分離已成為至關重要的上游工程。這些先進治療方法的生產和純化依賴於精準的細胞分離技術。持續的大規模生物製藥研發投入與細胞分離平台的日益普及直接相關，並將這些技術整合到藥物研發和生產的核心基礎設施中。

幹細胞研究和再生醫學的快速發展是推動這一趨勢的另一個重要因素。幹細胞在組織修復、疾病建模和藥物篩檢方面具有巨大的潛力，但要充分發揮這一潛力，需要高效的技術來分離、純化和鑑定特定的幹細胞群。在這一領域，科學界和臨床界的關注度日益提高，加之各方的不懈努力和積極倡導，持續推動著對專用分離試劑、試劑盒和設備的需求，這些試劑、試劑盒和設備旨在處理這些脆弱而珍貴的細胞。

市場發展正受到戰略投資舉措和政府大力支持的積極推動。生態系統內的企業已獲得大量資金，用於推動平台技術、擴大商業化進程並強化產品系列。這種私營部門的發展勢頭與旨在促進生物技術和先進製造領域創新的公共津貼和政策舉措相輔相成。此類財政和監管支持將加速新型細胞分離方法從實驗室轉化為更廣泛的商業性和臨床應用。

儘管前景樂觀，但市場仍面臨技術和營運方面的限制。分離純度和特異性方面仍有挑戰，某些調查方法有共分離非目標細胞的風險。此外，先進技術通常需要專門的操作知識和精密儀器，這可能會限制其在資源匱乏環境中的普及和廣泛應用。高通量應用的可擴展性也是高效處理大量樣本的持續性技術挑戰。透過持續創新克服這些限制因素，將是開啟下一階段市場滲透的關鍵。

從地理角度來看，北美有望繼續保持主導得益於其完善的製藥和生物技術產業基礎、高度集中的研究機構以及對尖端生命科學技術的早期應用。該地區慢性病的高發生率進一步凸顯了對先進細胞分離產品的臨床和商業性需求。旨在加強生物技術和生物製造能力的國家戰略舉措有望進一步鞏固這一區域優勢。

在競爭格局中，成熟的全球性公司提供全面的產品系列。它們憑藉自身專業知識，提供從以微珠為基礎、自動化細胞分選儀到用於科學研究和臨床的專用試劑盒等一系列整合解決方案。持續專注於創新、策略合作以及拓展應用支援，對於在這個不斷變化的市場中獲取價值至關重要。

總而言之，細胞分離市場受到醫療保健、工業和研究領域強大且相互關聯的促進因素的支持。其成長並非僅僅源於樣本量的增加，而是與推動下一代醫學突破的根本需求密切相關。行業相關人員的成功將取決於克服技術挑戰、提高產品的可及性和易用性，以及使產品開發適應治療方法發現、生物製造和臨床診斷不斷變化的需求。

本報告的主要優勢：

  • 深入分析：獲得主要和新興地區的深入市場洞察，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、行業垂直領域和其他細分市場。
  • 競爭格局：了解全球主要參與者的策略舉措，並了解透過正確的策略實現市場滲透的潛力。
  • 市場促進因素與未來趨勢：探索推動市場的動態因素和關鍵趨勢，以及它們將如何塑造未來的市場發展。
  • 可操作的建議：利用這些見解，在快速變化的環境中做出策略決策，並發現新的商機和收入來源。
  • 受眾廣泛：適用於Start-Ups、研究機構、顧問公司、中小企業和大型企業，且經濟實惠。

以下是一些公司如何使用這份報告的範例

產業與市場分析、機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法規結構及影響、新產品開發、競爭情報

研究範圍：

  • 2021年至2025年的歷史數據和2026年至2031年的預測數據
  • 成長機會、挑戰、供應鏈前景、法規結構與趨勢分析
  • 競爭定位、策略和市場佔有率分析
  • 按業務板塊和地區（包括國家）分類的收入和預測評估
  • 公司概況（策略、產品、財務資訊、關鍵發展等）

目錄

第1章執行摘要

第2章 市場概覽

  • 市場概覽
  • 市場定義
  • 調查範圍
  • 市場區隔

第3章 商業情境

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 波特五力分析
  • 產業價值鏈分析
  • 政策與法規
  • 策略建議

第4章 技術展望

第5章 依產品類型分類的細胞分離市場

  • 介紹
  • 消耗品
  • 裝置

第6章 細胞分離市場：依方法分類

  • 介紹
  • 離心
  • 濾
  • 螢光活化細胞分選（FACS）
  • 磁激活細胞分選（MACS）
  • 其他

第7章 細胞分離市場：依應用領域分類

  • 介紹
  • 生物分子分離
  • 癌症研究
  • 幹細胞研究
  • 組織再生
  • 體外診斷
  • 其他

第8章 依最終用戶分類的細胞分離市場

  • 介紹
  • 製藥和生物技術公司
  • 研究和學術機構
  • 其他

第9章 細胞分離市場：依地區分類

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 其他
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 印尼
    • 泰國
    • 其他

第10章 競爭格局與分析

  • 主要企業和策略分析
  • 市佔率分析
  • 合併、收購、協議和合作
  • 競爭對手儀錶板

第11章 公司簡介

  • Thermo Fisher Scientific, Inc.
  • BD Biosciences（Becton Dickinson Company）
  • Danaher Corporation
  • Terumo Corporation
  • STEMCELL Technologies Inc.
  • Bio-Rad Laboratories, Inc.
  • Merck KGaA
  • Corning Inc.
  • Akadeum Life Sciences
  • QIAGEN NV
  • Miltenyi Biotec GmbH

第12章附錄

  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要收益
  • 調查方法
  • 簡稱
簡介目錄
Product Code: KSI061615766

Cell Separation Market, with a 8.86% CAGR, is anticipated to reach USD 11.765 billion in 2031 from USD 7.071 billion in 2025.

The cell separation market is positioned for sustained growth, driven by its foundational role in advancing modern biomedical research and therapeutic development. This sector, dedicated to isolating specific cell types from heterogeneous mixtures, is integral to progress across multiple high-impact fields. The convergence of rising global health challenges, expansion in biomanufacturing, and significant technological and financial investments underpins a robust commercial trajectory.

A primary catalyst for market expansion is the escalating global burden of chronic diseases, particularly cancer. Cell separation technologies are indispensable for deepening the understanding of disease mechanisms, identifying critical biomarkers, and developing targeted diagnostics and therapies. The isolation and analysis of rare cell populations, such as circulating tumor cells (CTCs), exemplify a transformative application, enabling minimally invasive monitoring of disease progression and treatment efficacy. This direct link to addressing prevalent oncological and other chronic conditions ensures persistent demand for sophisticated separation solutions.

Concurrently, the robust expansion of the biopharmaceutical industry represents a major growth pillar. As the sector intensifies its focus on complex biologics-including monoclonal antibodies, recombinant proteins, and cell-based therapies-reliable and scalable cell separation becomes a critical upstream process. The production and purification of these advanced therapeutic modalities are contingent on precise cell isolation techniques. Substantial and ongoing investments in biopharmaceutical research and development directly correlate with increased adoption of cell separation platforms, embedding these technologies within the core infrastructure of drug development and manufacturing.

Further momentum is generated by the accelerating frontier of stem cell research and regenerative medicine. The potential of stem cells in tissue repair, disease modeling, and drug screening is vast, yet realizing this potential hinges on the ability to efficiently isolate, purify, and characterize specific stem cell populations. Rising scientific and clinical focus on this field, supported by dedicated initiatives and advocacy, continues to boost demand for specialized separation reagents, kits, and instruments designed to handle these sensitive and valuable cells.

Market advancement is actively propelled by strategic investment initiatives and substantive government support. Companies within the ecosystem are securing significant funding to advance platform technologies, scale commercialization efforts, and enhance product portfolios. This private sector momentum is complemented by public grants and policy initiatives aimed at fostering innovation in biotechnology and advanced manufacturing. Such financial and regulatory support accelerates the translation of novel cell isolation methodologies from research laboratories to broader commercial and clinical applications.

Despite a positive outlook, the market faces certain technical and operational restraints. Challenges pertaining to the purity and specificity of separation remain, with risks of non-target cell co-isolation in certain methodologies. Furthermore, advanced techniques often require specialized operational expertise and sophisticated instrumentation, which can limit accessibility and adoption in resource-constrained settings. Scalability for high-throughput applications also presents an ongoing engineering hurdle for processing large sample volumes efficiently. Addressing these limitations through continuous innovation is key to unlocking the next phase of market penetration.

From a geographical perspective, North America is anticipated to maintain a leadership position. This is attributed to its well-established pharmaceutical and biotechnology ecosystem, a high concentration of research institutions, and the early adoption of cutting-edge life science technologies. A significant prevalence of chronic diseases in the region further underscores the clinical and commercial need for advanced cell separation products. Strategic national initiatives aimed at reinforcing biotechnology and biomanufacturing capabilities are expected to further solidify this regional dominance.

The competitive landscape features established global players offering comprehensive portfolios. Companies leverage their expertise to provide integrated solutions, from magnetic bead-based reagents and automated cell sorters to specialized kits for research and clinical applications. Their continued focus on innovation, strategic collaborations, and expanding application support will be crucial in capturing value in this evolving market.

In summary, the cell separation market is underpinned by strong, interlinked drivers from healthcare, industry, and research. Its growth is not merely a function of increasing sample volumes but is fundamentally tied to enabling next-generation medical breakthroughs. Success for industry participants will depend on navigating technical challenges, enhancing accessibility and ease-of-use, and aligning product development with the evolving needs of therapeutic discovery, bioproduction, and clinical diagnostics.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2021 to 2025 & forecast data from 2026 to 2031
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.)

Cell Separation Market Segmentation

  • By Product Type
  • Consumables
  • Instrument
  • By Method
  • Centrifugation
  • Filtration
  • Fluorescence-activated Cell Sorting (FACS)
  • Magnetic-Activated Cell Sorting (MACS)
  • Others
  • By Application
  • Biomolecule Isolation
  • Cancer Research
  • Stem Cell Research
  • Tissue Regeneration
  • In Vitro-Diagnostics
  • Others
  • By End-User
  • Pharmaceuticals & Bio-Tech Companies
  • Research & Academic Institute
  • Others
  • By Geography
  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. CELL SEPARATION MARKET BY PRODUCT TYPE

  • 5.1. Introduction
  • 5.2. Consumables
  • 5.3. Instrument

6. CELL SEPARATION MARKET BY METHOD

  • 6.1. Introduction
  • 6.2. Centrifugation
  • 6.3. Filtration
  • 6.4. Fluorescence-activated cell sorting (FACS)
  • 6.5. Magnetic-Activated Cell Sorting (MACS)
  • 6.6. Others

7. CELL SEPARATION MARKET BY APPLICATION

  • 7.1. Introduction
  • 7.2. Biomolecule Isolation
  • 7.3. Cancer Research
  • 7.4. Stem Cell Research
  • 7.5. Tisue Regeneration
  • 7.6. In Vitro-Diagnostics
  • 7.7. Others

8. CELL SEPARATION MARKET BY END-USER

  • 8.1. Introduction
  • 8.2. Pharmaceuticals & Bio-Tech Companies
  • 8.3. Research & Academic Institute
  • 8.4. Others

9. CELL SEPARATION MARKET BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. USA
    • 9.2.2. Canada
    • 9.2.3. Mexico
  • 9.3. South America
    • 9.3.1. Brazil
    • 9.3.2. Argentina
    • 9.3.3. Others
  • 9.4. Europe
    • 9.4.1. Germany
    • 9.4.2. France
    • 9.4.3. United Kingdom
    • 9.4.4. Spain
    • 9.4.5. Others
  • 9.5. Middle East and Africa
    • 9.5.1. Saudi Arabia
    • 9.5.2. UAE
    • 9.5.3. Israel
    • 9.5.4. Others
  • 9.6. Asia Pacific
    • 9.6.1. China
    • 9.6.2. India
    • 9.6.3. Japan
    • 9.6.4. South Korea
    • 9.6.5. Indonesia
    • 9.6.6. Thailand
    • 9.6.7. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Market Share Analysis
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Competitive Dashboard

11. COMPANY PROFILES

  • 11.1. Thermo Fisher Scientific, Inc.
  • 11.2. BD Biosciences (Becton Dickinson Company)
  • 11.3. Danaher Corporation
  • 11.4. Terumo Corporation
  • 11.5. STEMCELL Technologies Inc.
  • 11.6. Bio-Rad Laboratories, Inc.
  • 11.7. Merck KGaA
  • 11.8. Corning Inc.
  • 11.9. Akadeum Life Sciences
  • 11.10. QIAGEN N.V.
  • 11.11. Miltenyi Biotec GmbH

12. APPENDIX

  • 12.1. Currency
  • 12.2. Assumptions
  • 12.3. Base and Forecast Years Timeline
  • 12.4. Key Benefits for the Stakeholders
  • 12.5. Research Methodology
  • 12.6. Abbreviations